Eris acquired Biocon Biologics’ domestic branded formulation business for Rs 1,242 crore in Q4FY24 and dermatology and nephrology units in Q3FY24

Eris Lifesciences net profit drops 4.5% to Rs 89 crore in Q1FY25

Eris Lifesciences on Friday said its consolidated profit after tax declined by 4.5 per cent year on year to Rs 89 crore for the quarter ended on June 30, 2024. The drug maker had reported a profit after tax of Rs 94 crore in the April-June quarter of the last fiscal.

Eris Lifesciences Q1 Results: Net dips 4.5% YoY at Rs 89 crore

ERIS Lifesciences consolidated net profit declines 12.31% in the June 2024 quarter

I feel markets are pretty volatile, so I have chosen few low beta counters. First one is Torrent Power, one could buy this at 1633, stop loss is 1540 and target is 1720 to 1800. And second one is Eris Lifesciences, one can buy this at 1124, 1080 is the stop loss and 1200 is the target.

2 top stock recommendations from Aditya Arora

Outlook on Nifty smallcap stocks: Delta Corp, Eris Life, Praj and Usha Martin can rally up to 28 per cent, while Symphony may witness a corrective move in the near-term; suggests technical charts.

Praj Delta Corp Trading strategies for 5 overbought NSE smallcap stocks

Efforts towards integrating the acquired business and reduce debt

Eris Lifesciences Q4 Results Review - Healthy Execution, Addition Of Business Drive The Quarter: Motilal Oswal

On CNBC-TV18 | Biocon Biologics sells Indian branded formulation biz to Eris Lifesciences for Rs 1,242 crore. MD & CEO, Shreehas Tambe tells Prashant Nair, Sonia Shenoy and Nigel D'Souza that the deal with Eris is not a restrictive but an enabling arrangement. 

#bioconbiologics #erislifesciences #formulationbusinesssale #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday

🔴CNBC TV18 LIVE TV: https://youtube.com/live/P857H4ej-MQ
SUBSCRIBE to our Channel: https://bit.ly/3nvEcxf
---------------------------------------------------------------------------------------------------------------------
👑 Check Out Top CNBC TV18 Playlist Videos: 
   
🔹CNBC TV18 Budget 2024: https://www.youtube.com/playlist?list=PLjq9mRS1PfGAh4mRbMxpMJTx7EXzii-Uf

🔹CNBC TV18 Digital Podcast: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCUcGVQvYyDQ6VVHoo3ZDKJ

🔹Sounding Board: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBbB2dV2tyHdzx_k9EqvVEm 

🔹International Videos: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDZ-Dkz-VpCDqqmWThJ3YJw

🔹CNBC TV18 Market Cafe: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDANftdnJchuL-WPpSv5rmH

🔹CNBC TV18 Digital: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDLhtM8FzErPcjmJRQ4I5cZ

🔹CNBC TV18 Weekend Special: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBHEa5NnoKuUsX5GwxEGuri

🔹CNBC TV18 Next-Gen: https://www.youtube.com/playlist?list=PLjq9mRS1PfGA6roe9q3J9fq_gBIDjX2w7

🔹Overdrive Show: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCnSVjfbWfNCJLrv-CqfGmH

🔹Young Turks: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBZaN1e38X2ZmevnU1e1NJs

🔹Startup Streets: https://www.youtube.com/playlist?list=PLjq9mRS1PfGD3CzrtMr_VJRbIly6sfyFI

------------------------------------------------------------------------------------
You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News
Follow us on Instagram: https://www.instagram.com/cnbctv18india/
Catch us on: Linkedin: https://in.linkedin.com/company/cnbc-tv18
n18oc_business

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.

Brands Wil Be Exclusive To Eris, Co Will Have Right To Commercialise These Brands: Biocon Biologics

Here are the top 10 stocks you need to keep on your radar in today's trading session. Take a look.

#topstocksinfocus #buzzingstocks #stockmarketupdates #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday

🔴CNBC TV18 LIVE TV: https://youtube.com/live/P857H4ej-MQ
SUBSCRIBE to our Channel: https://bit.ly/3nvEcxf
---------------------------------------------------------------------------------------------------------------------
👑 Check Out Top CNBC TV18 Playlist Videos: 
   
🔹CNBC TV18 Budget 2024: https://www.youtube.com/playlist?list=PLjq9mRS1PfGAh4mRbMxpMJTx7EXzii-Uf

🔹CNBC TV18 Digital Podcast: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCUcGVQvYyDQ6VVHoo3ZDKJ

🔹Sounding Board: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBbB2dV2tyHdzx_k9EqvVEm 

🔹International Videos: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDZ-Dkz-VpCDqqmWThJ3YJw

🔹CNBC TV18 Market Cafe: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDANftdnJchuL-WPpSv5rmH

🔹CNBC TV18 Digital: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDLhtM8FzErPcjmJRQ4I5cZ

🔹CNBC TV18 Weekend Special: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBHEa5NnoKuUsX5GwxEGuri

🔹CNBC TV18 Next-Gen: https://www.youtube.com/playlist?list=PLjq9mRS1PfGA6roe9q3J9fq_gBIDjX2w7

🔹Overdrive Show: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCnSVjfbWfNCJLrv-CqfGmH

🔹Young Turks: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBZaN1e38X2ZmevnU1e1NJs

🔹Startup Streets: https://www.youtube.com/playlist?list=PLjq9mRS1PfGD3CzrtMr_VJRbIly6sfyFI

------------------------------------------------------------------------------------
You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News
Follow us on Instagram: https://www.instagram.com/cnbctv18india/
Catch us on: Linkedin: https://in.linkedin.com/company/cnbc-tv18
n18oc_business

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.

Key Stocks In Focus: Paytm, Eris Lifesciences. Ashok Leyland, NCC, NHPC, Sundaram Clayton, Yes Bank

Execution remains key over next 15-18 months

Eris Lifesciences - Acquisition To Expand Diabetes Offerings, Add Oncology Products: Motilal Oswal

Eris Life Consolidated December 2023 Net Sales at Rs 486.30 crore, up 14.89% Y-o-Y

As of Monday, India has 1,475 active coronavirus cases. The maximum number of active cases is in Kerala (1,010), followed by West Bengal (182) and Maharashtra (116).

Centre Reviews Covid-19 Situation, Asks States To Keep Eye On New Variants Like Pirola, Eris

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Eris Lifesciences Limited is engaged in manufacturing, marketing and selling of generics within the chronic and acute categories of the Indian Pharmaceutical Market